- Find
- Manage
- Resources
New Triptans For Migraines
An experimental migraine treatment called telcagepant may offer hope for migraine patients who don't respond to older drugs. An online review in the Lancet of telcagepant found that it did not cause narrowing of the blood vessels--a side effect that can make it impossible for patients with heart problems to take triptans. Drugmaker Merck is planning to begin an U.S.-based clinical trial on the medication soon.
More information on "New Triptans For Migraines"
From Our Experts
12/10/07 #8: Triptans for basilar-type Migraine?
Full Question:What is your feeling about the use of triptans for basilar migraines which are not well controlled, despite high doses of... Read more »
Migraine abortive medications: triptan prices and patent expirations
Especially with the rising costs of health care (even for those of us with insurance), we have frequent discussions regarding the cost of... Read more »
8/13/07 #6: No triptans over 50?
Full Question:I am a woman of 63 years and have had migraines for years. They have gotten much better since I got off of... Read more »
Reporting from Chicago: A new Migraine abortive in trials.
Reporting from Chicago at the American Headache Society's 49th Annual Scientific Meeting...For a couple of years now, we've been watching,... Read more »
Antidepressants, Triptans, and Serotonin Syndrome
The Food and Drug Administration (FDA) issued a public health advisory (July, 2006) about potential risks of taking triptans together with... Read more »
From Our Sources
New Migraine Abortive Shows Promise without Vasoconstriction
Phase II study data on MK-0974, an investigational oral calcitonin gene-related peptide (CGRP) receptor antagonist showed:MK-0974 significantly... Read more »
Taking Triptans During Migraine Aura May Work Better
It's confusing. Some doctors tell us to take Migraine abortive medications such as the triptans early in a Migraine attack -- during the aura if... Read more »
Clinical trial: Combo med for triptan non-responders
This is a study to evaluate a new combination medication in migraine patients who don't respond well to triptans such as Imitrex and Relpax. This... Read more »
Migraines, Triptan Safety, and Pregnancy
Treating Migraines during a pregnancy has been a big problem for many women. All of the current Migraine abortives are FDA pregnancy C, which means... Read more »
Antidepressants and Migraine Drugs Don't Mix: FDA
THURSDAY, July 20 (HealthDay News) -- People who combine Prozac and similar antidepressants with migraine drugs called triptans run the risk of a... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
